FENG Wei-neng, DENG Qiu-mei. The Efficacy of Erlotinib Combined with Anti-Angiogenesis Treatment in Comparison with Erlotinib Alone as First-Line Treatment of EGFR-Mutated Advanced Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2020, 20(1): 53-57. DOI: 10.12019/j.issn.1671-5144.2020.01.012
|
Citation:
|
FENG Wei-neng, DENG Qiu-mei. The Efficacy of Erlotinib Combined with Anti-Angiogenesis Treatment in Comparison with Erlotinib Alone as First-Line Treatment of EGFR-Mutated Advanced Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2020, 20(1): 53-57. DOI: 10.12019/j.issn.1671-5144.2020.01.012
|
FENG Wei-neng, DENG Qiu-mei. The Efficacy of Erlotinib Combined with Anti-Angiogenesis Treatment in Comparison with Erlotinib Alone as First-Line Treatment of EGFR-Mutated Advanced Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2020, 20(1): 53-57. DOI: 10.12019/j.issn.1671-5144.2020.01.012
|
Citation:
|
FENG Wei-neng, DENG Qiu-mei. The Efficacy of Erlotinib Combined with Anti-Angiogenesis Treatment in Comparison with Erlotinib Alone as First-Line Treatment of EGFR-Mutated Advanced Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2020, 20(1): 53-57. DOI: 10.12019/j.issn.1671-5144.2020.01.012
|
DownLoad: